LGND Historical PE Ratio image   This LGND PE ratio history page last updated 2/26/2024
LGND Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2023
11/8/2023
52.231.024.0812.8
Q2 2023
8/8/2023
67.131.425.6811.8
Q1 2023
5/4/2023
76.712.289.128.4
Q4 2022
2/22/2023
72.121.365.4413.3
Q3 2022
11/7/2022
62.841.315.2412.0
Q2 2022
8/8/2022
61.921.034.1215.0
Q1 2022
5/4/2022
59.890.763.0419.7
Q4 2021
2/17/2022
70.001.807.209.7
Q3 2021
11/9/2021
94.751.586.3215.0
Q2 2021
7/29/2021
74.211.636.5211.4
Q1 2021
5/3/2021
90.601.415.6416.1
Q4 2020
2/3/2021
110.731.626.4817.1
Q3 2020
10/30/2020
51.431.044.1612.4
Q2 2020
8/3/2020
74.291.004.0018.6
Q1 2020
5/6/2020
63.310.893.5617.8
Q4 2019
2/6/2020
57.690.712.8420.3
Q3 2019
11/5/2019
69.700.491.9635.6
Q2 2019
7/30/2019
59.400.682.7221.8
Q1 2019
5/2/2019
79.301.164.6417.1
Q4 2018
2/7/2019
72.691.706.8010.7
Q3 2018
11/8/2018
106.791.325.2820.2
Q2 2018
8/6/2018
141.452.5910.3613.7
Q1 2018
5/8/2018
98.121.556.2015.8
Q4 2017
2/21/2018
97.531.315.2418.6
Q3 2017
11/9/2017
90.370.692.7632.7
Q2 2017
8/7/2017
76.000.672.6828.4
Q1 2017
5/9/2017
71.820.572.2831.5
Q4 2016
2/23/2017
64.151.255.0012.8
Q3 2016
11/3/2016
56.870.622.4822.9
Q2 2016
8/4/2016
82.600.502.0041.3
Q1 2016
5/4/2016
75.100.973.8819.4
Q4 2015
2/10/2016
55.060.662.6420.9
Q3 2015
11/9/2015
59.910.562.2426.7
Q2 2015
8/4/2015
68.191.817.249.4
Q1 2015
5/11/2015
52.670.331.3239.9
Q4 2014
2/9/2015
34.030.602.4014.2
Q3 2014
10/27/2014
33.830.361.4423.5
Q2 2014
8/4/2014
33.720.240.9635.1
Q1 2014
5/7/2014
40.780.351.4029.1
Q4 2013
2/11/2014
44.520.351.4031.8
Q3 2013
10/30/2013
34.070.120.4871.0
Q2 2013
8/1/2013
30.580.070.28109.2
Q1 2013
5/8/2013
16.760.070.2859.9
Q4 2012
2/13/2013
12.940.130.5224.9
Q3 2012
11/5/2012
10.74-0.01-0.04NA
Q2 2012
8/8/2012
11.30-0.20-0.80NA
Q1 2012
5/2/2012
8.020.060.2433.4
LGND PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2023
11/8/2023
52.231.026.088.6
Q2 2023
8/8/2023
67.131.426.3710.5
Q1 2023
5/4/2023
76.712.285.9812.8
Q4 2022
2/22/2023
72.121.364.4616.2
Q3 2022
11/7/2022
62.841.314.9012.8
Q2 2022
8/8/2022
61.921.035.1712.0
Q1 2022
5/4/2022
59.890.765.7710.4
Q4 2021
2/17/2022
70.001.806.4210.9
Q3 2021
11/9/2021
94.751.586.2415.2
Q2 2021
7/29/2021
74.211.635.7013.0
Q1 2021
5/3/2021
90.601.415.0717.9
Q4 2020
2/3/2021
110.731.624.5524.3
Q3 2020
10/30/2020
51.431.043.6414.1
Q2 2020
8/3/2020
74.291.003.0924.0
Q1 2020
5/6/2020
63.310.892.7722.9
Q4 2019
2/6/2020
57.690.713.0419.0
Q3 2019
11/5/2019
69.700.494.0317.3
Q2 2019
7/30/2019
59.400.684.8612.2
Q1 2019
5/2/2019
79.301.166.7711.7
Q4 2018
2/7/2019
72.691.707.1610.2
Q3 2018
11/8/2018
106.791.326.7715.8
Q2 2018
8/6/2018
141.452.596.1423.0
Q1 2018
5/8/2018
98.121.554.2223.3
Q4 2017
2/21/2018
97.531.313.2430.1
Q3 2017
11/9/2017
90.370.693.1828.4
Q2 2017
8/7/2017
76.000.673.1124.4
Q1 2017
5/9/2017
71.820.572.9424.4
Q4 2016
2/23/2017
64.151.253.3419.2
Q3 2016
11/3/2016
56.870.622.7520.7
Q2 2016
8/4/2016
82.600.502.6930.7
Q1 2016
5/4/2016
75.100.974.0018.8
Q4 2015
2/10/2016
55.060.663.3616.4
Q3 2015
11/9/2015
59.910.563.3018.2
Q2 2015
8/4/2015
68.191.813.1022.0
Q1 2015
5/11/2015
52.670.331.5334.4
Q4 2014
2/9/2015
34.030.601.5522.0
Q3 2014
10/27/2014
33.830.361.3026.0
Q2 2014
8/4/2014
33.720.241.0631.8
Q1 2014
5/7/2014
40.780.350.8945.8
Q4 2013
2/11/2014
44.520.350.6173.0
Q3 2013
10/30/2013
34.070.120.3987.4
Q2 2013
8/1/2013
30.580.070.26117.6
Q1 2013
5/8/2013
16.760.07-0.01NA
Q4 2012
2/13/2013
12.940.13-0.02NA
Q3 2012
11/5/2012
10.74-0.01NANA
Q2 2012
8/8/2012
11.30-0.20NANA
Q1 2012
5/2/2012
8.020.06NANA
Quotes delayed 20 minutes

Email EnvelopeFree LGND Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ligand Pharmaceuticals (LGND) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LGVN PE Ratio History
LH PE Ratio History
LHCG PE Ratio History
LHDX PE Ratio History
LIFE PE Ratio History
LIXT PE Ratio History
LJPC PE Ratio History
LLY PE Ratio History
LMAT PE Ratio History
LMNX PE Ratio History
How should the LGND historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Ligand Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LGND Historical PE Ratio page.

What is the average historical PE for LGND based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LGND historical PE ratio using the annualized quarterly earnings method works out to 24.5.

What is the average historical PE for LGND based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LGND historical PE ratio using the TTM earnings method works out to 25.0.

What is the average historical PE for LGND based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The LGND historical PE ratio using the annualized median TTM earnings method works out to 5.56.

On this page we presented the LGND Historical PE Ratio information for Ligand Pharmaceuticals' stock. The average LGND historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 24.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LGND historical PE based on this TTM earnings result method is 25.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LGND historical PE result, against the recent PE: when this page was posted on 2/23/2024, the most recent closing price for LGND had been 75.87, and the most recent quarterly earnings result, annualized, was 4.08. Meanwhile, the most recent TTM earnings summed to 6.08. From these numbers, we calculate the recent LGND PE on 2/23/2024 based on annualized quarterly EPS was 18.6. Based on LGND's history, that recent PE is low relative to the historical average, with the recent PE 24.1% lower than the historical average PE across our data set for Ligand Pharmaceuticals. Looking at the recent LGND PE on 2/23/2024 based on TTM EPS, we calculate the ratio at 12.5. Based on LGND's history, that recent PE is low relative to the historical average, with the recent PE 50.0% lower than the average PE across our Ligand Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting LGND historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for LGND, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for LGND, we start with the past four EPS numbers and we first sort them from lowest to highest: 1.02, 1.36, 1.42, and 2.28. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 1.36 and 1.42 — which gives us the median of 1.39. Basically the way to think about this 1.39 number is this: for the trailing four earnings reports, 1.39 marks the "middle ground" number where LGND has reported a value higher than 1.39 half the time, and has reported a value lower than 1.39 half the time. Annualizing that median value then gets us to 5.56/share, which we use as the denominator in our next PE calculation. With 75.87 as the numerator (as of 2/23/2024), the calculation is then 75.87 / 5.56 = 13.6 as the LGND PE ratio as of 2/23/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on LGND or any other given stock, valuation analysis for LGND can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Ligand Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LGND. Thanks for visiting, and the next time you need to research LGND Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CVRX shares outstanding history, ONEOK Average Annual Return, QQQX Historical Stock Prices.

 

LGND Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.